Therapeutic Rab7a inhibition to maintain growth factor receptor density and subsequent growth factor responsiveness to protect islets may therefore be an effective approach to enable beta cells to survive the metabolic stress they are subjected to during diabetes pathogenesis. The gene discussed is RAB7A; the disease is diabetes mellitus.